| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This report examines the background to the whole MI market, providing
estimates and evaluation in key areas and examining in-depth the companies,
innovative products and academic research that are driving change.
Molecular imaging is radically impacting the diagnosis of disease and the
development of pharmaceuticals.
Molecular Imaging (MI) encompasses a range of rapidly developing diagnostic
imaging techniques that combine new-generation imaging agents and advanced
imaging tools to capture specific molecular pathways in the body, particularly
disease targets.
The clinical benefits of MI are clear. If potentially lethal conditions such
as cancer or cardiovascular disease can be detected before they take hold,
patient outcomes can improve and healthcare costs will fall as the need for
surgery or late-stage treatments declines. When MI reaches its full potential,
it will fundamentally change the diagnosis and treatment of disease.
Much has happened recently in the field of MI. Many companies have entered
this new market and advanced contrast agents and imaging systems have been
launched, with more nearing commercialisation. New alliances, mergers and
acquisitions have taken place to bolster companies' prospects in the field,
with market leaders beginning to emerge.
The MI sector faces challenges: the agreement of standards and the development
of imaging technology and agents capable of being able to provide a meaningful
image at the cellular level. Few in the industry see these providing
significant hurdles to progress.
“Advances in imaging technology, along with increased understanding
of molecular and cellular processes, will revolutionise the early diagnosis
and treatment of major diseases”
The emergence of molecular imaging strategies is largely due to recent
unprecedented advances in molecular and cell biology techniques, the use of
transgenic animal models, availability of newer imaging drugs and probes that
are highly specific, and successful development of small-animal imaging
instrumentation.
These factors, along with continued expansion of scientific horizons in the
current post-genomic era, have been pivotal in the drive toward a new standard
that allows linking established in vitro and cell culture experimental assays
to imaging studies within living subjects.
TABLE OF CONTENTS
MOLECULAR IMAGING
- Molecular Imaging Modalities
- Imaging technologies - comparison of characteristics
- New MR-PET Hybrid Imaging Technology
- Imaging Biomarkers
- Drug Development
- Initiatives for the Advancement of Molecular Imaging
- Microdosing in Phase 0 Trials
- Shortening Timelines for Drug Development
- SNM
- ACRIN
- Collaborative Imaging Biomarker Center
- Disease Focus - Key Areas
- Alzheimer's Disease
- Cancer
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Cardiovascular Disease
- Challenges for Molecular Imaging Product Development
- Summary - Challenges for Imaging in Clinical Trials
- MARKET ESTIMATES
- Fig.1: Medical Imaging Market, 2005-2010E (EUR billion)*
- Fig.2: Medical Imaging Systems Market by Modality, 2005*
- Fig.3: Medical Imaging Systems Market by Region, 2005*
- Imaging Agent Manufacturers - 2006 Revenues*
- Fig.4. Imaging Agent Manufacturers, Market Share 2006
- Fig.5. Global Market for Imaging Agents 2005-2020, EUR Million
- INDUSTRY HIGHLIGHTS
MOLECULAR IMAGING COMPANIES
- AGENIX
- ThromboView
- Recent Highlights
- ThromboView Market Forecast
- Divestitures
- Funding
- AION DIAGNOSTICS
- Molecular Imaging Candidate
- Hybrid Contrast Agent
- Marking Agent
- ANTICANCER
- Products
- MetaMouse, AngioMouse, OncoBrite and GeneBrite
- OncoBrite
- MetaMouse - AngioMouse
- Fluorescence Imaging Technology Patents
- Research and Development
- Therapeutic Product Pipeline
- Diagnostic Product Pipeline
- Agreements
- INDEC Systems
- Olympus
- Roswell Park Cancer Institute
- ART ADVANCED RESEARCH TECHNOLOGIES
- eXplore Optix MX2
- Time Domain (TD) Optical Imaging Technology
- SoftScan
- Fenestra
- Development Pipeline - Second-generation Systems
- Acquisitions
- Alerion
- Dr. Joseph Lakowicz' MI Patent Portfolio
- Alliances
- GE Healthcare
- LAB Preclinical Research International
- Financials
- Financial Highlights (in US$)
- AVID RADIOPHARMACEUTICALS
- Clinical study of PET imaging with AV-1 in patients with AD
- Agreements
- MDS Nordion
- Bayer Schering Pharma AG
- Development Pipeline
- Intellectual Property
- Funding
- BAYER SCHERING PHARMA AG
- Licensing and Research Agreements
- Stanford University
- Taisho Pharmaceutical Co. Ltd., Nihon Nohyaku Co. Ltd., and the
National Institute of Radiological Sciences, Japan
- Molecular Insight Pharmaceuticals
- Philips Medical Systems
- Financials
- BIOMODA
- BIOSCAN
- Products
- Imaging Systems
- PET Chemistry/Nuclear Medicine
- Agreements
- BIOSPACE MED
- Molecular Imaging Activities
- In Vitro Imaging
- In Vivo Imaging
- β MICROPROBE
- γ IMAGER
- γ IMAGER-S
- Φ IMAGER
- First Clinical Product - Ultra-low-Dose 2D/3D Full-body X-ray Scanning
Device
- BOSTON LIFE SCIENCES
- Altropane - Parkinson's Disease
- Altropane - Attention Deficit Hyperactivity Disorder
- Technetium-based agents
- Imaging Approach
- Development Programme
- PET Imaging Agents
- Licensing Agreement
- Financials
- BRACCO
- Products
- Bracco Neuroimaging Clinical Trial Project
- Agreements
- VisualSonics
- Epix Pharmaceuticals
- Research and Development
- Financials
- BRISTOL-MYERS SQUIBB MEDICAL IMAGING
- Imaging Agents
- Cardiolite
- Definity
- Miraluma
- MI Agreements
- GE Healthcare
- Kereos
- DRAXIS Health
- AnorMed
- ImaRx Therapeutics
- BRUKER BIOSPIN
- MRI Products
- BioSpec Series
- BioSpec 117/16 - 11.7T USR Preclinical MRI System
- BioSpec 94/30 USR - 9.4T USR Preclinical MRI System
- ClinScan 7T High Field System for Preclinical Imaging
- PharmaScan - MRI System for Pharmaceutical Industry and Biotechnology
- Customised Systems
- MedSpec 4T - Dedicated Head Scanner for Clinical & Neuroscientific
Research
- ParaVision Software for Preclinical MR Imaging Research
- Ultra short echo time image of the rat lung
- Fourier Flow Imaging
- MRI CryoProbe
- New Signal-to-Noise Horizons in Small Animal MRI
- Bruker BioSpin NMR Division
- Avance III Spectrometer
- Magnet
- New project at Tübingen - 16.4T Horizontal Animal MRI Systems
- CALIPER LIFE SCIENCES/XENOGEN
- IVIS Imaging Systems and Living Image Software
- Living Image Software Version 2.5
- Living Image Software 3D Analysis Package
- Light Producing Cells and Microorganisms
- Light Producing Animal Models
- Reagents
- VivoFluor Fluorescence Labelling Kits
- D-Luciferin Potassium Salt
- Drug Discovery and Development Services
- Competitors
- Agreements
- Pfizer
- Molecular Probes
- Merck
- Taconic Farms
- Patents and Litigation
- Biophotonic Imaging Patents
- Financials
- Fiscal 2006
- Outlook for Fiscal 2007
- CAMBRIDGE ISOTOPE LABORATORIES (CIL)
- ROVER - PET Evaluation Software
- CANGEN BIOTECHNOLOGIES
- Microsatellite Analysis (MSA)
- Mass Spectrum (MS) Analysis
- Research Agreements
- Strategic Partners
- Johns Hopkins University
- JSR Corporation
- CARDINAL HEALTH
- Financials
- Supply Chain Services - Pharmaceutical
- First Nine Months of Fiscal 2007 to 31st March 2007 (US$ million)
- Outlook
- CELLPOINT
- EC Technology
- EC Technology (8 Diagnostic Imaging Agents)
- 99mTc-EC-G
- Other EC technology Imaging Agents for SPECT
- Imaging Agents for PET Applications
- EC Technology (4 Therapeutic Agents)
- 188Re-EC-G
- In Situ Hydrogel
- N4 Technology
- Oligosaccharide Conjugates / Dual-agent Technology
- Beta Cell Technology
- Research Agreements
- Philips Medical Systems
- M. D. Anderson Cancer Center
- Business Model
- Patents
- CYTOGEN
- ProstaScint
- Validation of PSMA Prognostic Value
- ProstaScint Market Opportunity
- Development Pipeline
- Abtides
- Oral Drug Delivery Technology
- Clinical Trials
- CYT-500 Radiolabelled Monoclonal Antibody
- Quadramet Phase II Study - New Indication for Prostate Cancer
- Agreements
- InPharma AS
- Rosemont Pharmaceuticals
- Bristol-Myers Squibb Medical Imaging
- Laureate Pharma
- Holopack Verpackungstechnik GmbH
- Oncology Therapeutics Network, J.V
- Dow Chemical
- Financials
- Fiscal 2006
- First Quarter of 2007
- Funding
- DRAXIS HEALTH
- DRAXIMAGE Sestamibi
- Cardiac Imaging with Tc-99m Sestamibi
- Technetium Generators
- European Entry
- Infecton
- Other New Product Opportunities
- MI Alliances
- Isotope Products Laboratories
- Bristol-Myers Squibb
- Bracco
- CARESTREAM HEALTH (KODAK HEALTH GROUP)
- Kodak Molecular Imaging Products
- In-Vivo Imaging Systems
- In-Vivo Multispectral
- In-Vivo FX Pro
- In-Vivo FX and F systems
- Kodak Image Station Systems
- Kodak In Vitro Molecular Imaging Systems
- Gel Logic 2200
- Gel Logic 1500
- Gel Logic 200
- Gel Logic 100
- Imaging Software and Agents
- Kodak MI Software, Regulatory Edition
- Kodak X-Sight Imaging Agents
- EPIX PHARMACEUTICALS
- Drug Discovery and Development
- Agreements
- GlaxoSmithKline
- Amgen
- Cystic Fibrosis Foundation Therapeutics
- Bayer Schering Pharma
- Siemens Medical Solutions
- Philips Medical Systems
- GE Healthcare
- Target Visual Technology
- Financials
- First Quarter of Fiscal 2007
- FLUOROPHARMA
- Product Pipeline
- CardioPET
- BFPET and VasoPET
- Market Opportunity
- Funding
- GAMMA MEDICA
- Clinical Imaging Systems
- Agreement to acquire Advanced Molecular Imaging
- FLEX Triumph Preclinical Imaging Systems
- Improvements added to the 2nd generation FLEX Triumph System
- X-O
- X-PET
- X-SPECT
- Agreements
- Johns Hopkins University
- Siemens
- Funding
- GE HEALTHCARE
- GE Healthcare Diagnostic Imaging's Molecular Imaging Activities
- Preclinical Imaging Products
- eXplore Vista
- eXplore Vista PET/CT
- eXplore Locus in vivo MicroCT
- eXplore Locus Ultra Pre-Clinical CT
- eXplore Locus SP
- eXplore Optix
- Clinical Imaging Products
- Discovery PET/CT Systems
- Discovery Dimension
- PET VCAR (Volume Computer-Assisted Reading)
- Infinia SPECT/CT Systems
- Infinia Hawkeye 4
- Other Nuclear Imaging Systems
- Xeleris 2
- Cyclotrons
- FASTlab
- TRACERlab
- Medical Diagnostics
- MI Products
- Myoview
- DaTSCAN
- Ceretec
- Optison Ultrasound Imaging Agent
- MI Licensing Agreement
- Mergers and Acquisitions
- Amersham
- IDX Systems Corporation
- Abbott's In Vitro Diagnostics Business
- Research and Development
- Molecular Imaging Study Areas
- Alzheimer's Disease
- Cardiovascular Disease
- Novel MRI Contrast Agents
- Antibody Technology
- R&D Projects
- PET Imaging Agent to Track Angiogenesis in Cancer
- Research Agreements
- University of Pittsburgh
- Mayo Clinic and Gamma Medica
- Oxford University
- St Joseph's Hospital and Medical Center
- Roche
- Eli Lilly
- Stanford University School of Medicine
- Texas A&M University System
- National Cancer Institute
- University of Washington
- Montefiore Medical Center
- Affibody
- Isogenica
- Pieris Proteolab
- St Joseph's Hospital and Medical Center
- University of California, San Fransciso
- Beth Israel Deaconess Medical Center
- Applera
- Financials
- GE Healthcare Operating Results, 2002-2006 (US$ billion)
- Fiscal 2006
- First Quarter of Fiscal 2007
- GLAXOSMITHKLINE
- Research Agreements
- Aarhus University Hospitals
- GUERBET
- Combidex/Sinerem
- Research Areas
- Oncology
- Cardiovascular Disease
- Research Agreements
- Financials
- 2007 First Quarter Sales and Outlook
- Fiscal 2006
- HAMAMATSU PHOTONICS
- Products
- Animal PET Scanner SHR-7700
- Aequoria
- Development of New Labelled Compounds
- Other Imaging Technologies
- RDOT: Reflectance Diffuse Optical Tomography (Optical CT*)
- Financials
- IBA (ION BEAM APPLICATIONS)
- Radiopharmaceuticals
- Mergers and Acquisitions
- Bayer Schering Pharma AG's Radiopharmaceutical Operations
- Eastern Isotopes
- New Mexico Positron and Lubbock West Texas Positron
- Divestitures
- Financials
- IMAGING DIAGNOSTIC SYSTEMS
- CTLM system
- Laser Imager for Lab Animals (LILA)
- Patents
- KEREOS
- Product Pipeline
- R&D Collaborations
- Washington University
- Dow Chemical Company
- Bristol-Myers Squibb Medical Imaging (BMSMI)
- Philips Medical Systems
- LIGHTOOLS RESEARCH
- MI Products
- Pan-A-See-Ya Panorama
- Illumatool Bright Light System
- Macro-Imaging System Plus
- MACROCYCLICS (MAGNETIC RESONANCE SOLUTIONS)
- Research and Development
- Research Agreements
- MDS Nordion
- University of Texas at Dallas
- Research Grants
- National Cancer Institute
- MALLINCKRODT (COVIDIEN)
- Products
- Computed Tomography Contrast Media
- Magnetic Resonance Contrast Media
- Radiopharmaceuticals
- Nuclear Cardology
- Financials
- MDS NORDION
- Products
- Medical Isotopes and Radiopharmaceuticals
- Research Agreements
- University of Ottawa Heart Institute
- Avid Radiopharmaceuticals
- Bradmer Pharmaceuticals
- Molecular Insight Pharmaceuticals
- Macrocyclics
- Financials
- First Quarter of 2007
- Fiscal 2006
- MEDISCIENCE TECHNOLOGY
- Basis for Technology
- Initial Products
- CD-Ratiometer
- Compact Photonic Pill
- Funding
- Market Size
- Alliances
- Alfanix Technology
- Infotonics Technology Center
- City University of New York (CUNY)
- City College's Institute for Ultrafast Spectroscopy and Lasers
- Stokes Shift Emission Spectroscopy
- MILABS
- Products
- U-SPECT II Scanners
- Resolution - 0.35 mm in 3 dimensions (0.04 μl)
- Dynamic 4D imaging
- MIR PRECLINICAL SERVICES
- MIR - Services
- Efficacy Testing
- Imaging
- Pharmacokinetics
- Pharmacodynamics
- Drug Efficacy Testing in Models of Rheumatoid Arthritis (Experimental)
- In Vitro Services
- Preclinical Consulting
- Validation of Clinical Imaging Technologies
- Model Development
- Evaluation of Imaging Contrast Agents
- Independent Research
- Imaging Systems
- Proprietary Technology
- In Vivo Caspase 3 Activation Assay
- Ef-luc Transgenic Mouse
- Agreements
- Licensing Agreements
- Biophotonic Imaging - Xenogen
- Funding
- State of Michigan's 21st Century Jobs Fund
- SBIR Grant
- Facility
- MOLECULAR INSIGHT PHARMACEUTICALS
- Product Pipeline
- Zemiva
- Clinical Profile and Development
- Azedra
- Onalta
- Other Pipeline Product Candidates
- Oncology - Solazed
- Prostate Cancer
- Trofex (MIP-220)
- Cardiology - MIP-190
- Neurology - MIP-170D
- Acquisitions
- Radiopharmaceutical Manufacturing Facility
- Agreements
- Bayer Schering Pharma
- Novartis Pharma AG
- MDS Nordion
- Eastern Isotopes (Ion Beam Applications)
- Recent R&D Highlights
- Financials
- First quarter of 2007
- Molecular Insight Operational Guidance
- Patents
- MOLECULAR NEUROIMAGING
- Clinical Ligand Innovation Program (CLIP)
- Clinical Imaging Site Coordination and Management (CLIC)
- MNI Resources and Capabilities
- NAVISCAN PET SYSTEMS
- Products
- Agreements
- Funding
- OLYMPUS
- In Vivo Imaging Systems
- IV100 Intravital Laser Scanning System
- OV100 Small Animal Imaging System
- Acquisitions and Alliances
- Single Molecule Fluorescence Spectroscopy - Evotec Technologies
- VisEn Medical
- Cangen Biotechnologies
- AntiCancer
- PHILIPS MEDICAL SYSTEMS
- MI Products
- Preclinical Imaging Systems
- Clinical Products
- Precedence SPECT/CT Systems
- BrightView
- JETStream Workspace 3.0
- Gemini PET/CT Systems
- Additional New Product Offerings
- Gamma Cameras
- Agreements
- MRI Research Facility
- Research Collaborations
- University Medical Center Hamburg-Eppendorf (UKE)
- MRI/PET Image Software Tool
- Organon
- BG Medicine
- Dartmouth College
- Bayer Schering Pharma AG
- CellPoint
- Kereos
- Epix Pharmaceuticals
- Financials
- First Quarter of Fiscal 2007
- Fiscal 2006
- Key Financial Data, 2004-2006
- PHOTOMETRICS (ROPER SCIENTIFIC)
- Products
- Lumazone CM Manual Chemiluminescence System
- Lumazone CA Automated Chemiluminescence System
- Lumazone FM Manual Fluorescence System
- Lumazone FA Automated Fluorescence System
- Spectral Imaging System for Fluorescence Microscopy
- POSITRON
- Products
- Agreements
- Dr. George Diamond - Cadenza Software
- Mayerick Corporation
- Funding
- Patents
- SA INSTRUMENTS
- Small Animal Monitoring and Gating Products
- Model 1025 Monitoring and Gating System
- Model 1025L Monitoring and Gating System
- SIEMENS MEDICAL SOLUTIONS
- Products
- Clinical Imaging
- Biograph PET-CT Systems with TruePoint Technology
- TruePoint SPECT-CT Systems
- SPECT
- c.cam
- e.cam Signature Series
- Symbia S
- Clinical Applications
- Preclinical Imaging
- PETNET Solutions
- Research and Development
- Imaging Biomarker for Alzheimer's Disease Phase I Clinical Trial
- FL-thymidine (FLT)
- Serum HER-2/neu
- Ultrasound - Liver Fibrosis Markers
- MR Imaging - Magnetic Nanoparticles
- IT Integration
- Prototype Hybrid MRI-PET Imaging System
- Siemens' Molecular Imaging Biomarkers Research Facility
- Abu Dhabi - First Molecular Imaging Centre
- Research Agreements
- Wyeth Pharmaceuticals
- University of Texas M. D. Anderson Cancer Center
- Center for Molecular Imaging Research (CMIR)
- Cytogen and University Hospitals of Cleveland
- VisEn Medical
- Commissariat à l'Energie Atomique
- Emory University
- Licensing Agreements
- Acquisitions
- Bayer Diagnostics and Diagnostic Products Corporation
- CTI Molecular Imaging
- Financials
- Fiscal 2006
- Fiscal 2007
- First Quarter of Fiscal 2007
- Second Quarter of Fiscal 2007
- SPECTRUM DYNAMICS
- Products
- D-SPECT Cardiac Imaging System
- Future Products
- TK SIGNAL
- Funding
- Research Projects
- ULTRASPECT
- Products
- Xpress.cardiac
- Xact.bone
- Xpress.bone
- Funding
- VISEN MEDICAL
- Animal Imaging Products
- Optical Probes
- MMPSense - Probes capable of visualising MMP activity in tumours and
other sites of inflammation
- AngioSPARK - Probes capable of enabling prolonged in vivo observation
- AminoSPARK - Probes capable of enabling fluorescent tagging of
target molecules
- ProSense
- AngioSense
- OsteoSense
- Superhance
- VivoTag
- Genhance
- Fluorescence Molecular Tomographic (FMT) Imaging System
- Clinical Product Development
- MI Alliances
- Merck
- Olympus
- Analogic
- Siemens
- VISUALSONICS
- Micro-ultrasound
- Applications
- Techniques
- Image-guided Injection
- Screening
- Blood Flow Analysis
- 3D Visualisation
- Agreements
- Bracco
- University of Virginia
- WILEX
- Agreements
- Financial Results
- ZECOTEK MEDICAL SYSTEMS
- PET-MRI Research Project - University of Washington
- Scintillation Crystals
- Silicon Photo-Multiplier
- OCT Light Source - University of British Columbia
- Funding
- Patent Applications
- ZYGOGEN
- Z-Tag and Z-Lipotrack Zebrafish Technology
- Angiogenesis
- Anti-angiogenesis assay
- Pro-angiogenesis assay
- Neurodegeneration
- Thrombosis
- Toxicity
- Predict QT Prolongation in heart-specific fluorescent zebrafish
- Cytochrome P450 3A Activity
- Target Validation
- Compound Screening
- Licensing Agreements
- University of Minnesota - Morpholino Antisense Technology
- DanioLabs - Z-Tag
- SELECTED ACADEMIC AND RESEARCH INSTITUTIONS
- UNITED STATES
- Case Western Reserve University - NFCR Center for Molecular Imaging
- City of Hope
- Beckman Research Institute
- Division of Molecular Medicine
- Division of Medical Oncology & Therapeutics Research
- Duke University
- Duke Comprehensive Cancer Center
- Center for Molecular and Biomolecular Imaging (CMBI)
- Pulse Shaping and Heterodyne
- Johns Hopkins University
- JHU - In Vivo Cellular Molecular Imaging Center (ICMIC)
- Massachusetts General Hospital - Center for Molecular Imaging Research
- CMIR Programmes
- Clinical Discovery Program
- Mayo Clinic
- Patterns between MRI-detected tumours and contralateral tumours
- Mayo Clinic - Ramirez-Alvarado Lab (Protein Misfolding)
- Molecular Imaging of Alzheimer's Plaques
- Research Collaboration with Gamma Medica
- Memorial Sloan-Kettering Cancer Center
- PET Imaging Identifies Aggressive Kidney Cancers that Require Surgery
- Mount Sinai School of Medicine
- Combining Molecular Imaging Technologies To Stop/Prevent Heart
Attacks
- National Institutes of Health
- National Cancer Institute
- NIGMS - Exploratory Centres for the Development of High Resolution
Probes for Cellular Imaging
- Fluorescent Probes for Multiplexed Intracellular Imaging
- Sub-nm Dendrimer-Metal Nanoclusters as Ultrabright, Modular
Targeted in vivo Single Molecule Raman and Fluorescence Labels
- Single-Molecule Fluorophores for Cellular Imaging
- Bioaffinity Nanoparticle Probes for Molecular/Cellular Imaging
- Probes for Quantitative Optical and Electron Microscopy
- Imaging Single Proteins In Vivo with Quantum Dots
- Light-Activated Gene Expression in Single Cells
- Library-Based Development of New Optical Imaging Probes
- Genetically Targetable Labels for Light and EM
- Purdue University
- New Imaging Approach Promises Insights into Multiple Sclerosis
- Stanford University
- Molecular Imaging Program at Stanford
- Research on PET and CT separately and in combination in managing
patients with melanoma
- Center of Excellence for Cancer Early Detection
- Study findings - CT scans may reveal genetic activity of liver
tumours
- Thomas Jefferson University
- Circulating Tumour Cells Predict How Hormone-Resistant Prostate
Cancer Patients Fare
- Translational Genomics Research Institute (TGen)
- Alzheimer's Disease Study
- University of California
- University of California, Los Angeles (UCLA)
- Center for In Vivo Imaging in Cancer Biology
- UCLA - Department of Molecular and Medical Pharmacology
- Crump Institute for Molecular Imaging
- New Brain Imaging Compound Shows Promise For Earlier Detection of
Alzheimer's Disease
- University of California, San Diego (UCSD)
- University of California, Davis
- Center for Molecular and Genomic Imaging (CMGI)
- Cherry Laboratory - CMGI
- University of Chicago
- CAD technology may prove beneficial for tumour detection by PET
- University of Michigan Health System
- University of Minnesota
- PET-CT is better for early detection of muscular lymphoma than CT
alone
- University of Texas M.D. Anderson Cancer
- Center for Advanced Biomedical Imaging Research
- Department of Experimental Diagnostic Imaging
- Targeted Molecular Imaging of Cancer
- Washington University, St. Louis
- Mallinckrodt Institute of Radiology
- Optical Radiology Laboratory (ORL)
- Lewis Lab
- Center for Clinical Imaging Research
- Cardiovascular Magnetic Resonance Imaging Laboratories (CMRL)
- Siteman Center of Cancer Nanotechnology Excellence
- Nanoparticles can track cells deep within living organisms
- CANADA
- McMaster Institute of Applied Radiation Sciences (McIARS)
- University of Toronto, Ontario
- Laboratory of Molecular Imaging and Targeted Radiotherapeutics
- EUROPE
- Belgium
- University Hospital of Liège
- Finland
- Kuopio University, A.I Virtanen Institute for Molecular Sciences
- France
- CEA
- SHFJ - First complete simulation of PET imaging scan of entire human
body
- NeuroSpin
- CNRS / Université VI Paris, Paris, France
- Targeted and Functional Ultrasound, Laboratoire d'Imagerie
Paramétrique - UMR 7623
- CNRS / University Victor Segalen, Bordeaux
- Molecular and Functional Imaging: From Physiology to Therapy
Technological Research Team
- Germany
- Technical University of Munich, Munich
- Fraunhofer Institute/Medical School, Hanover
- Italy
- University of Milan, Milan
- Centre of Excellence on Neurodegenerative Diseases
- Netherlands
- Netherlands Cancer Institute
- Department of Radiology
- Impact of preoperative contrast-enhanced MRI in patients eligible
for breastconserving therapy: update on 325 patients15
- Benefit of semi-automatic volumetric measurement of extent of breast
tumours from contrast-enhanced MRI
- Accurate extent definition of non-small cell lung tumours using
pathology validated PET-CT
- Optimising functional imaging approaches in a preclinical setting;
molecular imaging in mice
- Sweden
- Uppsala University
- Karolinska Institutet, Uppsala, Sweden
- Department of Geriatric Medicine, Neurotec and Uppsala PET Centre /
Imanet
- Collaboration with AstraZeneca
- United Kingdom
- Cancer Research UK
- Imperial College of Science, Technology and Medicine, London,
- Neurology Group, MRC Clinical Sciences Centre, Hammersmith Hospital
- Oxford University - Centre for Functional Magnetic Resonance Imaging
of the Brain (FMRIB)
- University of Durham
- University of Manchester - Wolfson Molecular Imaging Centre,
- University of Cambridge - Wolfson Brain Imaging Centre
- University of Edinburgh, Edinburgh
- SHEFC Brain Imaging Centre for Scotland, West of Scotland
Radionuclide Dispensary, and Institute of Neurological Sciences Glasgow
- ASIA
- Japan
- National Institute of Radiological Sciences - Molecular Imaging Center
- MIC Diagnostic Imaging Group
- Molecular Diagnosis Team
- Biomolecule Team
- MIC - Molecular Neuroimaging Group
- Molecular Neurobiology Team
- System Neurochemistry Team
- Molecular Probe Group
- Probe Research Team
- Biophysics Group
- MR Molecular Imaging Team
- Biosignal Physiology Team
- Imaging Analysis Team
- Imaging Physics Team
- AUSTRALIA
- Austin Hospital, Melbourne
- Study - Amyloid Imaging in the Differential Diagnosis of Dementia
- University of Sydney, Sydney
- Academic Research Institute /Industry Collaborations
REFERENCES
REPORT METHODOLOGY
|
